Stocks › SNN
Smith & Nephew SNATS, Inc. (SNN) stock analysis
SKIP 6% confidence · analysed Oct 1, 2026
On Oct 1, 2026, our model rated Smith & Nephew SNATS, Inc. (SNN) SKIP with 6% confidence at a price of $26.44. That means the signals cancel out; the model sees no clear edge either way.
Technical picture
The 14-day RSI is 37. Momentum is soft: below the neutral 50 line, but not yet oversold.
MACD is below its signal line, so short-term momentum is pointing down.
The price is below both its 50-day and 200-day moving averages, the classic picture of a downtrend.
Volume is only 0.5x its 20-day average; light trading makes the latest move less convincing.
Trend structure and money flow
Market structure shows a bearish break of structure (BOS): price broke a recent swing low in the direction of the trend, which usually signals trend continuation.
The most recent swing high is $36.54 and the swing low is $31.35; traders often treat these as resistance and support.
Price is sitting in a bullish order block, a zone where large buyers stepped in before.
Fundamentals
The PEG ratio is 1.03, which looks reasonably priced for its growth.
The company reports a profit margin of 10.1% and revenue growth of +4.6%.
In its latest quarter it earned $0.51 per share, which missed the $0.53 analysts expected.
Wall Street's average rating is 2.8 on a 1 (strong buy) to 5 (sell) scale, roughly a "hold", with an average price target of $32.72.
The next earnings report is expected around Mar 1, 2027; prices often move sharply around earnings.
The model's one-paragraph read
No clear edge (SKIP) — composite score -0.06 (SKIP). Technicals: RSI 37.26, MACD bearish, price below SMA50. Fundamentals: PEG 1.03, margin 10.1%, revenue growth 4.6%. Financial results: last EPS surprise -3.8%, next earnings 2027-03-01. Smart Money Concepts: BOS bearish (trend continuation), price retesting a bullish order block. FinGPT news read: positive. Memory: 1 prior look(s). Reference price $26.51; no trade levels (SKIP).
Past ratings for SNN
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Oct 1, 2026 | SKIP | 6% | $26.44 | — |
"Move since" compares each call's price with the latest analysed price.
Other Healthcare stocks we cover
STE · TCMD · TKNO · UNH · ZBH · ALC · AMGN · AMRX · ANIP · ASTH · ATEC · ATRC
Frequently asked questions
Is SNN a buy right now?
As of Oct 1, 2026, our automated model rates Smith & Nephew SNATS, Inc. (SNN) SKIP with 6% confidence: the signals cancel out; the model sees no clear edge either way. This is a model output for education, not personal investment advice.
When does Smith & Nephew SNATS, Inc. report earnings next?
The next earnings report is expected around Mar 1, 2027.
What does a SKIP rating mean?
A SKIP rating means the signals cancel out; the model sees no clear edge either way.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.